Selection and autologous transplantation of rhG-CSF mobilized CD133+cells from peripheral blood in patients with indolent non Hodgkin's lymphoma under high-dose chemotherapy.

被引:0
|
作者
Falzetti, F [1 ]
Ballanti, S [1 ]
De Ioanni, M [1 ]
Di Ianni, M [1 ]
Zugarini, V [1 ]
Piattoni, S [1 ]
Battelli, F [1 ]
Zei, T [1 ]
Ostini, RI [1 ]
Martelli, MF [1 ]
Tabilio, A [1 ]
机构
[1] Univ Perugia, Hematol & Clin Immunol Sect, I-06100 Perugia, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3280
引用
收藏
页码:831A / 831A
页数:1
相关论文
共 50 条
  • [1] Mobilization of peripheral blood stem cells by mitoxantrone and high-dose cytarabine chemotherapy and rhG-CSF from patients with hematopoietic malignancies.
    Qiu, HY
    Wu, DP
    Sun, AN
    Jin, ZM
    Ruan, CG
    BLOOD, 2003, 102 (11) : 417B - 417B
  • [2] Mobilization of peripheral blood progenitor cells for allogeneic transplantation: Efficacy and toxicity of a high-dose rhG-CSF regimen
    Waller, CF
    Bertz, H
    Wenger, MK
    Fetscher, S
    Hardung, M
    Engelhardt, M
    Behringer, D
    Lange, W
    Mertelsmann, R
    Finke, J
    BONE MARROW TRANSPLANTATION, 1996, 18 (02) : 279 - 283
  • [3] Tandem transplantation with high-dose etoposide mobilized peripheral blood stem cells in patients with primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma.
    Glossmann, JP
    Nogova, L
    Reiser, M
    Engert, A
    Diehl, V
    Josting, A
    BLOOD, 2002, 100 (11) : 649A - 649A
  • [4] Cytokines for priming and mobilization of peripheral blood progenitor cells (PBPC) in patients undergoing high-dose chemotherapy (HDC) with peripheral stem cell transplantation (PSCT): Sequential administration of rhGM-CSF and rhG-CSF versus rhG-CSF alone.
    Isaacs, RE
    Jennis, A
    Zahos, K
    Cantwell, S
    Roseti, S
    Doria, L
    Corcoran, S
    Murphy, L
    Wisniewski, AM
    Michelis, MA
    Pecora, AL
    BLOOD, 1996, 88 (10) : 3669 - 3669
  • [5] Autologous tandem transplantation with high-dose etoposide mobilised peripheral blood stem cells in patients with refractory Hodgkin's and aggressive non-Hodgkin lymphoma
    Sieniawski, M
    Glossmann, JP
    Staak, JO
    Nogova, L
    Kisro, J
    Rudolph, C
    Reiser, M
    Scheid, C
    Engert, A
    Diehl, V
    Josting, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S251 - S252
  • [6] Treatment of patients with Hodgkin disease with high-dose chemotherapy followed by autologous peripheral blood stem cells transplantation.
    Czyz, J
    Knopinska-Posluszny, W
    Lewandowski, K
    Mital, A
    Prejzner, W
    Halaburda, K
    Bieniaszewska, M
    Hellmann, A
    BONE MARROW TRANSPLANTATION, 1999, 23 : S103 - S103
  • [7] High-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma
    Provencio, Mariano
    Fayad, Luis E.
    MEDICINA CLINICA, 2008, 130 (02): : 60 - 65
  • [8] Phenotypic changes in neutrophils after rhG-CSF administration in non-Hodgkin's lymphoma patients undergoing PBSC transplantation or conventional chemotherapy
    Carulli, G
    Papineschi, F
    Benedetti, E
    Vanacore, R
    Azzarà, A
    Petrini, M
    HAEMATOLOGICA, 1999, 84 (03) : 281 - 283
  • [9] BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients
    Kim, J.
    Kim, E.
    Sohn, B.
    Yoon, D.
    Yoo, C.
    Kim, S.
    Lee, D.
    Kim, S.
    Lee, J.
    Suh, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] BEAM OR BUCYE HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION IN NON-HODGKIN'S LYMPHOMA PATIENTS
    Suh, C.
    Kim, J. E.
    Sohn, B. S.
    Yoon, D. H.
    Lee, D. H.
    Kim, S. W.
    Lee, J. S.
    Kim, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 643 - 643